Introduction — Inflammation isn’t a disease: it’s a biological language
Inflammation is one of life’s most fundamental biological mechanisms. It is an essential adaptive response to injury, infection and tissue repair. Without acute inflammation, there is no wound healing, no effective immune defence, and ultimately no survival [1].
Over the past few decades, ageing biology has brought another reality into focus: when inflammation stops being transient and well regulated, and becomes chronic, diffuse and silent, it turns into a major driver of biological ageing [2,3]. This persistent inflammation no longer protects; it progressively degrades the cellular environment and disrupts the body’s adaptive mechanisms.
This phenomenon — now known as inflammaging — is not a classic inflammatory disease. It refers to a state of persistent, low-grade inflammatory activation, often asymptomatic, that gradually develops with age and precedes the onset of chronic disease [3–5]. It operates upstream of clinical symptoms, sometimes over several decades.
Inflammaging does not present as acute flare-ups, but as a slow drift in the biological environment. That drift impairs cellular function, accelerates loss of resilience, reduces repair capacity, and progressively weakens physiological systems — creating the biological terrain for accelerated ageing [2,6].
I — Scientific definition of inflammaging
The term inflammaging was introduced by Claudio Franceschi to describe a central ageing paradox: with age, the immune system becomes less effective against infections and pathogens (immunosenescence), while paradoxically remaining chronically activated [3,7].
Inflammaging is defined as a systemic, persistent state of chronic low-grade inflammation, resulting from continuous activation of innate inflammatory pathways, in the absence of any identifiable acute infectious trigger [3,8]. It is an inappropriate, non-resolving form of inflammation that no longer fulfils a protective role.
It is characterised by:
- a moderate but sustained rise in pro-inflammatory cytokines such as IL-6, TNF-α and IL-1β [6,9],
- persistent activation of major inflammatory signalling pathways, notably NF-κB and JAK/STAT [2,10],
- chronic stimulation of intracellular inflammatory platforms such as the NLRP3 inflammasome [11],
- ongoing, bidirectional interplay with metabolism, the gut microbiota and cellular stress [4,12].
Unlike classic inflammatory diseases, inflammaging is diffuse, multifactorial and cumulative. It is not confined to a single organ: it gradually permeates the whole organism, durably reshaping the overall biological terrain in which cells operate [3,5].
II — Acute inflammation vs chronic inflammation: a fundamental distinction
It is essential to clearly distinguish two biologically opposite forms of inflammation — in both mechanism and consequence [1,13].
Acute inflammation
Acute inflammation is fast, localised and time-limited. Its purpose is to eliminate an immediate threat — infection, injury, aggression — and then resolve once the danger has been contained. It supports tissue repair and a return to homeostasis [1,13].
It is protective, regulated and indispensable.
Chronic low-grade inflammation
By contrast, chronic low-grade inflammation is slow, diffuse and persistent. It is not driven by an identifiable acute infection and does not resolve spontaneously. It maintains a continuous state of cellular stress, often clinically silent [2,6].
This chronic inflammation is not an effective response: it is background biological “noise” that durably disrupts cellular signalling, diverts metabolic resources, and undermines adaptive capacity [6,9].
This is precisely the form of inflammation that accelerates biological ageing [3–6].
III — Why inflammaging accelerates biological ageing
Biological ageing is not simply the passive accumulation of damage. It is the progressive loss of coherence, plasticity and resilience across biological networks [14,15].
Chronic inflammation acts as a systemic disorganiser, across several interdependent levels [2,6].
1. Disruption of cellular signalling
Inflammatory cytokines profoundly alter how cells interpret their environment. They interfere with:
- nutrient-sensing pathways (mTOR, AMPK, IGF-1) [15–17],
- insulin signalling and glycaemic regulation [6,9],
- cellular repair and maintenance mechanisms [14],
- epigenetic regulation of genes involved in longevity [18,19].
Cells then operate in a permanent stress mode, prioritising immediate survival over long-term maintenance [14,15].
2. Inflammation-driven mitochondrial dysfunction
Chronic inflammation directly impairs mitochondrial function:
- increased ROS production [20],
- reduced energetic efficiency [21],
- disruption of mitophagy [22],
- release of mitochondrial danger signals (mitochondrial DNA) [23].
Dysfunctional mitochondria become pro-inflammatory themselves, amplifying inflammasome activation and innate immune signalling [11,20]. A self-reinforcing loop emerges between inflammation, energy loss and oxidative stress [20–22].
3. Activation of cellular senescence
Chronic exposure to an inflammatory environment promotes cellular entry into senescence [24,25]. Senescent cells stop dividing but remain metabolically active and secrete a set of inflammatory and proteolytic mediators known as the SASP [24–26].
This senescent phenotype:
- sustains local and systemic inflammation [25],
- disrupts neighbouring tissue function [26],
- reduces tissue regenerative capacity [25].
Inflammaging thus becomes both a cause and a consequence of cellular senescence [24–26].
4. Epigenetic disorganisation
Chronic inflammation durably reshapes the epigenome:
- changes in DNA methylation [18,27],
- post-translational histone modifications [19],
- dysregulated gene expression programmes [18–20].
These shifts progressively orient cells towards less adaptive biological programmes, associated with reduced metabolic flexibility and accelerated ageing [14,18].
IV — The major biological sources of inflammaging
Inflammaging never results from a single factor. It emerges from the convergence of multiple biological stressors that often overlap and reinforce one another [3,6].
1. Nutrition-driven meta-inflammation
Chronic energy excess, repeated glycaemic spikes and lipid overload activate innate immunity via adipose tissue, the liver and metabolic macrophages [9,28]. This meta-inflammation, described notably in The Lancet, is one of the major drivers of modern inflammaging [6,9].
2. Gut dysbiosis and low-grade inflammation
The gut microbiota plays a central role in immune regulation [12,29]. With age — and under the influence of an unsuitable diet:
- microbial diversity decreases,
- intestinal permeability increases,
- bacterial endotoxins (LPS) enter the circulation [12,29].
This metabolic endotoxaemia sustains chronic systemic inflammation [29,30].
3. Chronic oxidative stress
Oxidative stress becomes pathological when it exceeds redox regulation capacity, aligns with persistent inflammation, and damages cellular repair mechanisms [20,31].
Inflammation and oxidative stress fuel each other in a harmful feedback loop [20,31].
4. Accumulation of senescent cells
With age, immune clearance of senescent cells becomes less effective. Their accumulation creates a long-lasting autonomous source of inflammatory cytokines, reinforcing inflammaging [24–26].
V — Inflammaging and age-related disease
Inflammaging does not cause a single specific disease. It creates a shared biological terrain that favours multiple age-associated pathologies:
- cardiovascular disease [6,32],
- type 2 diabetes and metabolic disorders [9,32],
- neurodegenerative disease [33],
- sarcopenia and frailty [6,34],
- cancers associated with ageing [35].
Chronic diseases can therefore be understood as different clinical expressions of the same underlying inflammatory imbalance [3,6].
VI — Why “eliminating inflammation” is a conceptual mistake
The goal is never to eliminate inflammation. Inflammation is indispensable to immunity, necessary for tissue repair, and essential for biological adaptation [1,13].
Trying to switch it off abruptly — particularly through chronic anti-inflammatory strategies — can weaken immune function, impair healing, and disrupt physiological balance [36].
The relevant strategy is to reduce inappropriate chronic inflammation, while preserving functional acute inflammation [3,6].
VII — Nutrition and inflammaging: a causal relationship, not a cosmetic one
Nutrition does not act like a pharmaceutical anti-inflammatory.
It acts upstream, by shaping the biological environment in which inflammatory pathways are expressed [9,12,28].
A relevant nutritional approach acts on:
- metabolic inflammatory load [9],
- the quality of energetic signals [15–17],
- gut microbiota integrity [12,29],
- mitochondrial capacity [20–22],
- redox balance [31].
This is precisely the framework in which Cellular Nutrition sits.
VIII — Cellular Nutrition in the context of inflammaging
Cellular Nutrition does not aim to “calm” inflammation superficially. It aims to restore the biological conditions that make inflammation unnecessarily chronic.
It acts simultaneously on:
- mitochondrial energy,
- reduction of pro-inflammatory metabolic signals,
- support of the gut microbiota,
- regulation of oxidative stress,
- coherence of nutritional signals perceived by the cell [14–17,20,29].
This systems-based approach is fully aligned with the ageing biology described in Cell, Nature and The Lancet [2–6,14].
Conclusion — Inflammaging: a modifiable lever of accelerated ageing
Inflammaging is neither an inevitability nor a passive by-product of ageing.
It is a central, partially modifiable mechanism that shapes the speed and quality of biological ageing [3–6].
Slowing biological ageing necessarily involves durably reducing chronic low-grade inflammation — not through suppression, but through restoring cellular coherence [14,15].
From this scientific, clinical and systems-based perspective, Cellular Nutrition stands out as a credible and rigorous lever of modern prevention.
Bibliography
[1] Medzhitov, R. (2008) Origin and physiological roles of inflammation. Nature, 454(7203), 428–435. Available at: https://www.nature.com/articles/nature07201
[2] López-Otín, C. et al. (2013) The hallmarks of aging. Cell, 153(6), 1194–1217. Available at: https://www.cell.com/cell/fulltext/S0092-8674(13)00645-4
[3] Franceschi, C. et al. (2000) Inflamm-aging: an evolutionary perspective on immunosenescence. Annals of the New York Academy of Sciences, 908, 244–254. Available at: https://pubmed.ncbi.nlm.nih.gov/10911963/
[4] Franceschi, C. and Campisi, J. (2014) Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. The Journals of Gerontology Series A, 69(Suppl 1), S4–S9. Available at: https://academic.oup.com/biomedgerontology/article/69/Suppl_1/S4/552493
[5] Ferrucci, L. and Fabbri, E. (2018) Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. The Lancet Diabetes & Endocrinology, 6(6), 505–514. Available at: https://www.thelancet.com/journals/landia/article/PIIS2213-8587(18)30104-2/fulltext
[6] Franceschi, C. et al. (2018) Inflammaging and longevity: a systems biology perspective. Nature Reviews Endocrinology, 14, 576–590. Available at: https://www.nature.com/articles/s41574-018-0059-4
[7] Fulop, T. et al. (2017) Immunosenescence and inflamm-aging as two sides of the same coin. Frontiers in Immunology, 8, 1960. Available at: https://www.frontiersin.org/articles/10.3389/fimmu.2017.01960/full
[8] Furman, D. et al. (2019) Chronic inflammation in the etiology of disease across the life span. Nature Medicine, 25, 1822–1832. Available at: https://www.nature.com/articles/s41591-019-0675-0
[9] Gregor, M.F. and Hotamisligil, G.S. (2011) Inflammatory mechanisms in obesity. The Lancet, 378(9786), 253–262. Available at: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(11)60827-5/fulltext
[10] Lawrence, T. (2009) The nuclear factor NF-κB pathway in inflammation. Cold Spring Harbor Perspectives in Biology, 1(6), a001651. Available at: https://cshperspectives.cshlp.org/content/1/6/a001651
[11] Guo, H., Callaway, J.B. and Ting, J.P. (2015) Inflammasomes: mechanism of action, role in disease. Nature Medicine, 21, 677–687. Available at: https://www.nature.com/articles/nm.3893
[12] Belkaid, Y. and Hand, T.W. (2014) Role of the microbiota in immunity and inflammation. Cell, 157(1), 121–141. Available at: https://www.cell.com/cell/fulltext/S0092-8674(14)00240-0
[13] Nathan, C. and Ding, A. (2010) Nonresolving inflammation. Cell, 140(6), 871–882. Available at: https://www.cell.com/cell/fulltext/S0092-8674(10)00128-7
[14] López-Otín, C. et al. (2023) Hallmarks of aging: an expanding universe. Cell, 186(2), 243–278. Available at: https://www.cell.com/cell/fulltext/S0092-8674(22)01377-0
[15] Johnson, S.C., Rabinovitch, P.S. and Kaeberlein, M. (2013) mTOR is a key modulator of ageing and age-related disease. Nature, 493, 338–345. Available at: https://www.nature.com/articles/nature11861
[16] Cantó, C. and Auwerx, J. (2012) AMPK–SIRT1–PGC-1α axis in mitochondrial biogenesis. Cell Metabolism, 15(5), 689–700. Available at: https://www.cell.com/cell-metabolism/fulltext/S1550-4131(12)00106-9
[17] Fontana, L. et al. (2010) Calorie restriction or pharmacological interventions? Science, 328(5976), 321–326. Available at: https://www.science.org/doi/10.1126/science.1172539
[18] Jaenisch, R. and Bird, A. (2003) Epigenetic regulation of gene expression. Nature Genetics, 33(Suppl), 245–254. Available at: https://www.nature.com/articles/ng1089
[19] Feil, R. and Fraga, M.F. (2012) Epigenetics and the environment. Nature Reviews Genetics, 13, 97–109. Available at: https://www.nature.com/articles/nrg3142
[20] Sun, N., Youle, R.J. and Finkel, T. (2016) The mitochondrial basis of aging. Molecular Cell, 61(5), 654–666. Available at: https://pubmed.ncbi.nlm.nih.gov/26942670/
[21] Picard, M. et al. (2014) Mitochondrial dysfunction and aging. Annual Review of Physiology, 76, 175–195. Available at: https://pubmed.ncbi.nlm.nih.gov/24224760/
[22] Green, D.R., Galluzzi, L. and Kroemer, G. (2011) Mitochondria and the autophagy–inflammation–cell death axis. Science, 333(6046), 1109–1112. Available at: https://www.science.org/doi/10.1126/science.1209167
[23] West, A.P. et al. (2015) Mitochondrial DNA stress primes the antiviral innate immune response. Nature, 520, 553–557. Available at: https://www.nature.com/articles/nature14156
[24] Campisi, J. and d’Adda di Fagagna, F. (2007) Cellular senescence: when bad things happen to good cells. Nature Reviews Molecular Cell Biology, 8, 729–740. Available at: https://www.nature.com/articles/nrm2233
[25] van Deursen, J.M. (2014) The role of senescent cells in ageing. Nature, 509, 439–446. Available at: https://www.nature.com/articles/nature13193
[26] Coppé, J.P. et al. (2010) The senescence-associated secretory phenotype. Annual Review of Pathology, 5, 99–118. Available at: https://pubmed.ncbi.nlm.nih.gov/20078217/
[27] Horvath, S. (2013) DNA methylation age of human tissues and cell types. Genome Biology, 14, R115. Available at: https://genomebiology.biomedcentral.com/articles/10.1186/gb-2013-14-10-r115
[28] Hotamisligil, G.S. (2017) Foundations of immunometabolism. Immunity, 47(3), 406–420. Available at: https://www.cell.com/immunity/fulltext/S1074-7613(17)30359-8
[29] Cani, P.D. et al. (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes, 56(7), 1761–1772. Available at: https://diabetesjournals.org/diabetes/article/56/7/1761/14855
[30] Tilg, H. and Moschen, A.R. (2014) Microbiota and inflammation. Nature Reviews Immunology, 14, 528–540. Available at: https://www.nature.com/articles/nri3703
[31] Reuter, S. et al. (2010) Oxidative stress, inflammation, and cancer. Free Radical Biology & Medicine, 49(11), 1603–1616. Available at: https://pubmed.ncbi.nlm.nih.gov/20840865/
[32] Furman, D. et al. (2017) Systems analysis of immune aging. Cell Systems, 4(1), 9–21. Available at: https://www.cell.com/cell-systems/fulltext/S2405-4712(16)30247-9
[33] Heneka, M.T. et al. (2015) Neuroinflammation in Alzheimer’s disease. The Lancet Neurology, 14(4), 388–405. Available at: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(15)70016-5/fulltext
[34] Bian, A.L. et al. (2017) Aging, sarcopenia, and inflammation. Ageing Research Reviews, 40, 1–17. Available at: https://pubmed.ncbi.nlm.nih.gov/28802695/
[35] Grivennikov, S.I., Greten, F.R. and Karin, M. (2010) Immunity, inflammation, and cancer. Cell, 140(6), 883–899. Available at: https://www.cell.com/cell/fulltext/S0092-8674(10)00141-X
[36] Calder, P.C. et al. (2017) Dietary factors and low-grade inflammation. Nutrients, 9(9), 938. Available at: https://www.mdpi.com/2072-6643/9/9/938
Glossary
Inflammation
A normal biological response of the immune system to a threat (infection, injury, toxin). It involves immune-cell activation, release of chemical mediators, and local and/or systemic changes aimed at eliminating the threat and repairing tissue.
Acute inflammation
A transient, targeted and regulated form of inflammation. It arises quickly, serves a specific purpose (defence, repair), and resolves once the threat is controlled. It is essential for survival.
Chronic low-grade inflammation
A persistent, diffuse, moderate inflammatory state, often without obvious symptoms. Unlike acute inflammation, it does not resolve and maintains constant cellular stress. It is implicated in biological ageing and chronic disease.
Inflammaging
Low-grade chronic inflammation associated with ageing. It is a state of persistent immune activation that precedes and promotes age-related pathologies by durably degrading the cellular environment.
Immunosenescence
Ageing of the immune system characterised by reduced effectiveness of adaptive immune responses, paradoxically accompanied by chronic activation of innate immunity.
Cytokines
Small signalling proteins produced by immune cells (and other cells) that enable intercellular communication. Some are pro-inflammatory (e.g., IL-6, TNF-α), others are anti-inflammatory.
IL-6 (Interleukin-6)
A pro-inflammatory cytokine involved in immunity, metabolism and ageing. Chronically elevated levels are associated with frailty, cardiovascular disease and mortality.
TNF-α (Tumour Necrosis Factor alpha)
A major pro-inflammatory cytokine. When persistently activated, it contributes to chronic inflammation, insulin resistance and tissue dysfunction.
IL-1β
A pro-inflammatory cytokine activated notably by the inflammasome. It plays a role in fever, inflammation and innate immune responses.
NF-κB
A central inflammatory transcription factor. Chronic activation promotes expression of many pro-inflammatory genes and contributes to inflammaging.
JAK/STAT
A cellular signalling pathway involved in cytokine responses. Persistent activation contributes to chronic inflammation and cellular ageing.
Inflammasome (NLRP3)
An intracellular protein complex that detects danger signals (cellular stress, mitochondrial damage). Chronic activation increases IL-1β production and low-grade inflammation.
Cellular stress
A state in which a cell is exposed to unfavourable conditions (oxidative stress, inflammation, metabolic overload), impairing normal function and adaptive capacity.
Oxidative stress
An imbalance between free-radical production (ROS) and antioxidant defences. When chronic, it damages proteins, lipids and DNA and fuels inflammation.
ROS (Reactive Oxygen Species)
Reactive oxygen-derived molecules. At low levels they have physiological roles; in chronic excess they become harmful.
Redox balance
The cell’s ability to maintain a healthy balance between ROS production and antioxidant defences. Disruption promotes inflammation and ageing.
Mitochondria
Cellular organelles responsible for energy production (ATP). They also play central roles in immune signalling, oxidative stress and biological ageing.
Mitochondrial dysfunction
Reduced capacity of mitochondria to produce energy efficiently, often accompanied by increased oxidative stress and pro-inflammatory signalling.
Mitophagy
Selective recycling of damaged mitochondria. A decline with age contributes to accumulation of dysfunctional mitochondria and inflammaging.
Mitochondrial DNA (mtDNA)
DNA specific to mitochondria. When released into the cytosol or circulation, it is perceived as a danger signal and activates innate immunity.
Cellular senescence
An irreversible state in which a cell stops dividing in response to significant stress. Senescent cells remain metabolically active and influence their environment.
SASP (Senescence-Associated Secretory Phenotype)
A set of cytokines, enzymes and pro-inflammatory factors secreted by senescent cells. SASP sustains chronic inflammation and disrupts neighbouring tissues.
Epigenetics
Mechanisms that regulate gene expression without changing DNA sequence. They enable the environment (nutrition, inflammation, stress) to durably influence cellular function.
DNA methylation
An epigenetic modification involving addition of methyl groups to DNA, influencing gene activation or repression.
Histones
Proteins around which DNA is wrapped. Chemical modifications change gene accessibility and expression.
Nutrient sensing
The cell’s ability to detect nutrient availability and adapt metabolism accordingly via pathways such as mTOR, AMPK and IGF-1.
mTOR
A signalling pathway involved in growth, protein synthesis and metabolism. Chronic activation is associated with accelerated ageing.
AMPK
A cellular energy sensor activated during low-energy states. It supports repair, autophagy and functional longevity.
Meta-inflammation
Chronic inflammation driven by metabolic imbalance (caloric excess, lipid overload, repeated glycaemic spikes), described in obesity and ageing.
Gut microbiota
The community of microorganisms living in the gut. It plays key roles in immunity, inflammation and metabolism.
Dysbiosis
An imbalance of the gut microbiota characterised by reduced diversity and an increase in pro-inflammatory species.
Intestinal permeability
Compromise of the gut barrier allowing molecules or bacteria to enter the bloodstream, promoting systemic inflammation.
Metabolic endotoxaemia
Chronic presence of bacterial endotoxins (LPS) in circulation, often driven by increased intestinal permeability.
Biological resilience
The organism’s capacity to adapt, recover from stress and maintain function. It declines with inflammaging.
Biological ageing
Functional ageing of cells and biological systems, distinct from chronological age. It is influenced by inflammation, metabolism and environment.
Cellular Nutrition
A systems-based nutritional approach that aims to optimise the cellular environment (energy, inflammation, microbiota, oxidative stress) to preserve biological coherence and functional longevity.
FAQ
What exactly is inflammaging?
Inflammaging refers to a persistent, systemic, low-grade inflammatory state that gradually develops with age. Unlike acute inflammation, it is not a short-term response to infection, but an ongoing activation that degrades the cellular environment and accelerates biological ageing.
What is the difference between chronic inflammation and inflammaging?
“Chronic inflammation” is a broad term covering many pathological situations. Inflammaging more specifically refers to age-associated low-grade chronic inflammation, characterised by moderate intensity, long duration, and a central role in age-related disease risk.
Is inflammaging inevitable with age?
No. Inflammaging is not a fate, but a partially modifiable process. While immune ageing contributes, environmental factors — nutrition, metabolism, microbiota, oxidative stress — strongly influence its intensity and how quickly it develops.
At what age does inflammaging begin?
Research suggests markers of chronic inflammation can appear from early adulthood — sometimes from the forties, or earlier in individuals with unfavourable metabolic terrain. Inflammaging is not tied to a specific age, but to the gradual accumulation of biological imbalances.
Can we measure inflammaging?
There is no single marker. It is typically assessed through a panel of measures: inflammatory cytokines (e.g., IL-6, high-sensitivity CRP), metabolic markers, immune profiles, and sometimes epigenetic data. Interpretation must always be global and contextual.
What are the main symptoms of inflammaging?
Inflammaging is often silent. When it manifests clinically, it may contribute to persistent fatigue, diffuse aches, metabolic issues, muscle frailty, reduced recovery, and increased vulnerability to chronic disease. These signs are non-specific and reflect altered biological terrain rather than one isolated illness.
Does inflammaging cause chronic diseases?
Not a single disease directly. It creates a biological terrain that favours many age-related pathologies, including cardiovascular disease, type 2 diabetes, neurodegeneration and sarcopenia.
Why does chronic inflammation accelerate biological ageing?
Because it durably disrupts core cellular mechanisms: mitochondrial energy production, metabolic signalling, cellular repair, gene expression and intercellular communication. This progressive disorganisation reduces resilience and accelerates functional ageing.
Is oxidative stress linked to inflammaging?
Yes. Oxidative stress and chronic inflammation are tightly connected. Chronic oxidative stress fuels inflammation, and inflammation increases free-radical production — forming a harmful loop central to inflammaging.
Does the gut microbiota play a role in inflammaging?
Yes — a central one. Dysbiosis and increased gut permeability allow endotoxins to enter circulation, sustaining systemic chronic inflammation. The microbiota is now recognised as a key actor in inflammaging.
Should we eliminate inflammation to slow ageing?
No. Eliminating inflammation would be biologically misguided. Inflammation is essential for immunity and repair. The goal is to reduce inappropriate chronic inflammation while preserving acute inflammatory responses necessary for survival.
Can anti-inflammatories fight inflammaging?
Pharmaceutical anti-inflammatories may relieve symptoms, but they are not a long-term strategy against inflammaging. Used chronically, they can disrupt immunity and mask underlying biological imbalances.
What is the link between nutrition and inflammaging?
Nutrition influences inflammaging by modulating metabolic inflammatory load, energy-signalling pathways, the gut microbiota, mitochondrial function and redox balance. It acts upstream, shaping biological terrain.
Are certain foods pro-inflammatory?
Certain dietary patterns can promote chronic inflammation when repeated long term: excess rapid sugars, ultra-processed foods, chronic caloric overload, and fatty-acid imbalance. The key factor is overall dietary coherence, not one food in isolation.
Can Cellular Nutrition reduce inflammaging?
Cellular Nutrition aims to create a less inflammatory cellular environment by acting simultaneously on multiple biological levers. It does not suppress inflammation; it reduces the conditions that make it chronic and harmful.
Can reducing inflammaging slow biological ageing?
Evidence suggests that improving long-term low-grade inflammation can influence the trajectory of biological ageing. It does not stop ageing, but can improve its quality, pace and functional consequences.
Is inflammaging reversible?
Not “fully reversible” in a simplistic sense, but it is modifiable. Improving biological terrain can reduce inflammaging intensity and restore some cellular resilience — especially when addressed early enough.
Why speak about prevention rather than treatment?
Because inflammaging develops slowly, long before symptoms. Acting early on nutrition, metabolism and inflammation helps preserve long-term biological function — which is true prevention of accelerated ageing.
Inflammaging and longevity: what is the real stake?
The goal is not to live indefinitely, but to age in good health. Limiting inflammaging helps preserve energy, autonomy, muscle function, immune competence and cognitive performance — extending functional lifespan.